Health Care Select Sector SPDR Fund

XLV

Market cap $35.2B

It's early days, but the fourth quarter has brought a change in market leadership at the sector level. Healthcare, one of the year's big laggards, is now the best performing S&P 500 sector so far in October.

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Health Care Select Sector SPDR ETF (XLV) is a passively managed exchange traded fund launched on December 16, 1998.

As AI-fueled gains spark bubble warnings, investors are eyeing defensive ETFs in consumer staples, utilities and healthcare for safety.

Morning Brief: Market Sunrise anchor Ramzan Karmali examines the biggest market news and stories for October 7, 2025. CFRA research analyst Angelo Zino comes on the program to talk more about AMD's AI chip deal with OpenAI, and what it all means for the former's semiconductor rivals.

Michelle Ross, StemPoint Capital CIO, joins 'Closing Bell' to discuss Ross' thoughts on the recent news in the biotech space, what the CIO expects to continue and much more.

The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.

The US stock market is highly concentrated, with technology and tech-related stocks now comprising about 55% of total market cap. This concentration justifies higher valuation multiples for SPY, as tech companies have stronger margins and more stable earnings than defensive sectors. There is a stark divergence in performance between speculative tech ETFs like ARKK and CHAT versus defensive dividend ETFs such as SCHD and VNQ.

The U.S. government shut down on Oct. 1, 2025, as last-minute talks failed. ETFs like TLT, XLV and PSCC hog attention.

The Fast Money traders discuss why health care stocks look attractive on valuations, how underweight positioning could drive sustainability, why recent White House policy moves may be a “gift” to pharma companies, and more.

Evan Seigerman, BMO Capital Markets head of healthcare research, joins 'Closing Bell' to discuss President Trump's latest tariff announcement on pharmaceutical companies, where execution needs to happen and much more.